Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Diploid-triploid mosaicism is a chromosome disorder. Individuals with diploid-triploid syndrome have some cells with three copies of each chromosome for a total of 69 chromosomes (called triploid cells) and some cells with the usual 2 copies of each chromosome for a total of 46 chromosomes (called diploid cells). Having two or more different cell types is called mosaicism. Diploid-triploid mosaicism can be associated withtruncal obesity, body/facial asymmetry, weak muscle tone (hypotonia), delays in growth,mild differences infacial features, fusion or webbing between some of the fingers and/or toes (syndactyly) and irregularities in the skin pigmentation. Intellectual disabilities may be present but are highly variable from person to person ranging from mild to more severe. The chromosome disorder is usually not present in the blood; a skin biopsy, or analyzing cells in the urine is needed to detect the triploid cells.
Biomarker and diagnostic research for diploid-triploid mosaicism has been reported in the published literature.
No clinical trials have been registered for diploid-triploid mosaicism.
18 publications have been identified in PubMed for diploid-triploid mosaicism. Research spans Diagnostic / Biomarker (39%), Basic Science / Preclinical (17%), and Epidemiology / Natural History (17%).
Research Type | Count | % of Total |
|---|---|---|
Testing and diagnosis research | 7 | 39% |
Data assembled from 2 of 12 sources · Last updated Sep 18, 2026, 11:34 PM UTC
Genetic and Rare Diseases Info Center
Laboratory research
3 |
17% |
Disease patterns and progression | 3 | 17% |
Research summaries | 2 | 11% |
Clinical study results | 2 | 11% |
Patient case studies | 1 | 6% |
Stewart R (2026). [PMID: 40838347](https://pubmed.ncbi.nlm.nih.gov/40838347/). *American journal of medical genetics. Part A*. [Case Report / Case Series]
Benn P (2026). [PMID: 41299888](https://pubmed.ncbi.nlm.nih.gov/41299888/). *Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology*. [Diagnostic / Biomarker]
Arntzen JW (2026). [PMID: 41553266](https://pubmed.ncbi.nlm.nih.gov/41553266/). *The Journal of heredity*. [Clinical Trial Publication]
Yang S (2026). [PMID: 41974762](https://pubmed.ncbi.nlm.nih.gov/41974762/). *Sci Rep*. [Epidemiology / Natural History]
Zhang H (2026). [PMID: 42087731](https://pubmed.ncbi.nlm.nih.gov/42087731/). *Zhonghua Yi Xue Yi Chuan Xue Za Zhi*. [Diagnostic / Biomarker]
Zhang Z (2026). [PMID: 42216025](https://pubmed.ncbi.nlm.nih.gov/42216025/). *Reprod Biol Endocrinol*. [Diagnostic / Biomarker]
Pery E (2026). [PMID: 42200562](https://pubmed.ncbi.nlm.nih.gov/42200562/). *Stem Cells Dev*. [Basic Science / Preclinical]
Zhu Y (2026). [PMID: 41943072](https://pubmed.ncbi.nlm.nih.gov/41943072/). *J Transl Med*. [Epidemiology / Natural History]
Nagao T (2025). [PMID: 40565573](https://pubmed.ncbi.nlm.nih.gov/40565573/). *Genes*. [Clinical Trial Publication]
Su B (2025). [PMID: 41379315](https://pubmed.ncbi.nlm.nih.gov/41379315/). *Marine biotechnology (New York, N.Y.)*. [Basic Science / Preclinical]